Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Duo Han, Shaihong Zhu, Xia Li, Zhiqiang Li, Hui Huang, Wenzhe Gao, Yunfei Liu, Hongwei Zhu & Xiao Yu. (2022) The NF-κB/miR-488/ERBB2 axis modulates pancreatic cancer cell malignancy and tumor growth through cell cycle signaling. Cancer Biology & Therapy 23:1, pages 294-309.
Read now
Read now
Ciara M. Kelly, Mazen El Bassiouni, Michael W. Bennett, Lee Crush, Peter McEneaney, Criostoir O’Suilleabhain & Derek G. Power. (2014) Borderline resectable pancreatic adenocarcinoma, is conversion therapy realistic?. Acta Oncologica 53:9, pages 1268-1271.
Read now
Read now
Articles from other publishers (20)
Yujia Wang, Ruixin Wang, Bowen Li, Zhuoshan Huang, Sufeng Zhao, Suling Chen, Tianjun Lan, Siqi Ren, Fan Wu, Jing Tan & Jinsong Li. (2023) Cancer-associated fibroblasts in the invasive tumour front promote the metastasis of oral squamous cell carcinoma through MFAP5 upregulation. Gene 876, pages 147504.
Crossref
Crossref
Indu Khatri & Manoj K. Bhasin. (2020) A Transcriptomics-Based Meta-Analysis Combined With Machine Learning Identifies a Secretory Biomarker Panel for Diagnosis of Pancreatic Adenocarcinoma. Frontiers in Genetics 11.
Crossref
Crossref
Mohammed Sikander, Shabnam Malik, Sheema Khan, Sonam Kumari, Neeraj Chauhan, Parvez Khan, Fathi T. Halaweish, Bhavin Chauhan, Murali M. Yallapu, Meena Jaggi & Subhash C. Chauhan. (2019) Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer). Cells 9:1, pages 103.
Crossref
Crossref
Tsz-Lun Yeung, Cecilia S. Leung, Kay-Pong Yip, Jianting Sheng, Long Vien, Laura C. Bover, Michael J. Birrer, Stephen T.C. Wong & Samuel C. Mok. (2019) Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer. Clinical Cancer Research 25:21, pages 6417-6428.
Crossref
Crossref
Yi‑Hang Yuan, Jian Zhou, Yan Zhang, Meng‑Dan Xu, Jing Wu, Wei Li, Meng‑Yao Wu & Dao‑Ming Li. (2019) Identification of key genes and pathways downstream of the β‑catenin‑TCF7L1 complex in pancreatic cancer cells using bioinformatics analysis. Oncology Letters.
Crossref
Crossref
Shuhua Shen, Tuantuan Gui & Chengcheng Ma. (2017) Identification of molecular biomarkers for pancreatic cancer with mRMR shortest path method. Oncotarget 8:25, pages 41432-41439.
Crossref
Crossref
Rhonda M. Jack, Meggie M. G. Grafton, Danika Rodrigues, Maria D. Giraldez, Catherine Griffith, Robert Cieslak, Mina Zeinali, Chandan Kumar Sinha, Ebrahim Azizi, Max Wicha, Muneesh Tewari, Diane M. Simeone & Sunitha Nagrath. (2016) Ultra‐Specific Isolation of Circulating Tumor Cells Enables Rare‐Cell RNA Profiling. Advanced Science 3:9, pages 1600063.
Crossref
Crossref
Alaa Afify, Eric C. Huang, Matthew Jeong & Shiro Urayama. (2015) Immunoisolation of pancreatic epithelial cells from endoscopic ultrasound‐guided fine needle aspirates with magnetic beads for downstream molecular application. Diagnostic Cytopathology 44:1, pages 32-38.
Crossref
Crossref
Shahid G. Farid & Gareth Morris-Stiff. (2015) “OMICS” technologies and their role in foregut primary malignancies. Current Problems in Surgery 52:10, pages 409-441.
Crossref
Crossref
DONG-YAN HAN, DA FU, HAO XI, QIAN-YU LI, LI-JIN FENG, WEI ZHANG, GUO JI, JIA-CHENG XIAO & QING WEI. (2015) Genomic expression profiling and bioinformatics analysis of pancreatic cancer. Molecular Medicine Reports 12:3, pages 4133-4140.
Crossref
Crossref
Amy S. Farrell, Brittany Allen-Petersen, Colin J. Daniel, Xiaoyan Wang, Zhiping Wang, Sarah Rodriguez, Soren Impey, Jessica Oddo, Michael P. Vitek, Charles Lopez, Dale J. Christensen, Brett Sheppard & Rosalie C. Sears. (2014) Targeting Inhibitors of the Tumor Suppressor PP2A for the Treatment of Pancreatic Cancer. Molecular Cancer Research 12:6, pages 924-939.
Crossref
Crossref
Christian Pilarsky & Robert Grützmann. 2014. Molecular Diagnostics and Treatment of Pancreatic Cancer. Molecular Diagnostics and Treatment of Pancreatic Cancer
151
167
.
Enrique Carrillo-de Santa Pau, Francisco X. Real & Alfonso Valencia. 2014. Molecular Diagnostics and Treatment of Pancreatic Cancer. Molecular Diagnostics and Treatment of Pancreatic Cancer
93
131
.
Yixing Jiang, Nicole DiVittore, Megan Young, Zhiliang Jia, Keping Xie, Timothy Ritty, Mark Kester & Todd Fox. (2013) Altered Sphingolipid Metabolism in Patients with Metastatic Pancreatic Cancer. Biomolecules 3:4, pages 435-448.
Crossref
Crossref
Stephan Gysin, Jesse Paquette & Martin McMahon. (2012) Analysis of mRNA Profiles after MEK1/2 Inhibition in Human Pancreatic Cancer Cell Lines Reveals Pathways Involved in Drug Sensitivity. Molecular Cancer Research 10:12, pages 1607-1619.
Crossref
Crossref
Zahra Piri, Abdolreza Esmaeilzadeh & Mehri Hajikhanmirzaei. (2012) Interleukin-25 as a candidate gene in immunogene therapy of pancreatic cancer. Journal of Medical Hypotheses and Ideas 6:2, pages 75-79.
Crossref
Crossref
Geng Zhang, Aaron Schetter, Peijun He, Naotake Funamizu, Jochen Gaedcke, B. Michael Ghadimi, Thomas Ried, Raffit Hassan, Harris G. Yfantis, Dong H. Lee, Curtis Lacy, Anirban Maitra, Nader Hanna, H. Richard Alexander & S. Perwez Hussain. (2012) DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma. PLoS ONE 7:2, pages e31507.
Crossref
Crossref
Chanjuan Shi & Ralph H. Hruban. (2012) Intraductal papillary mucinous neoplasm. Human Pathology 43:1, pages 1-16.
Crossref
Crossref
Ana C Tahira, Márcia S Kubrusly, Michele F Faria, Bianca Dazzani, Rogério S Fonseca, Vinicius Maracaja-Coutinho, Sergio Verjovski-Almeida, Marcel CC Machado & Eduardo M Reis. (2011) Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Molecular Cancer 10:1.
Crossref
Crossref
Young-Joon Surh, Ann M. Bode & Zigang Dong. (2010) Breaking the NF-κB and STAT3 Alliance Inhibits Inflammation and Pancreatic Tumorigenesis. Cancer Prevention Research 3:11, pages 1379-1381.
Crossref
Crossref